Covid- 19 Vaccine Storage Monitoring with Milesight

Worldwide, hundreds of thousands of people are falling seriously ill from COVID-19. Now the raising hopes are coming due to the promising interim results announced by two drugmakers, Pfizer and Moderna. But distributing presents a tough challenge to the local administration and government. The vaccine made by Pfizer needs to be kept in ultra-cold conditions from minus 70 to minus 90 degrees Celsius. Therefore, proper vaccine storage plays a very important role in maintaining vaccine efficacy. Milesight environmental monitoring solution has been deployed in pharmacies and hospitals for temperature monitoring to be compliant with the national requirements in governmental Health Care Facilities of Indonesia.

Milesight environmental monitoring solutions can protect the valuable vaccine supply with automated temperature monitoring and alerting. The EM500-PT100 temperature sensor with a cryogenic temperature probe made of platinum resistance thermometers can monitor storage units as cold as -328 °F (-200 °C).

In this environmental monitoring application, a PT100 temperature probe is put into the refrigeration units or freezers, and the transceiver EM500 collects data physically through a cable and communicates with Everynet gateway through the LoRaWAN® network. The sensors can support a wide temperature range either from -50°C to 200 °C or from -200°C to 50 °C, making the installer able to choose the best model according to the pharmaceutical storage equipment.